Delivering pharmacogenetic testing in a primary care setting

References

• WangLMcLeodHLWeinshilboumRMGenomics and drug responseN Engl J Med2011364121144115321428770
   PubMed Web of Science ®Google Scholar
• ManolioTAChisholmRLOzenbergerBImplementing genomic medicine in the clinic: the future is hereGenet Med201315425826723306799
   PubMed Web of Science ®Google Scholar
• CDC/NCHSNational Ambulatory Medical Care Survey: 2010 Summary TablesAtlanta, GACenters for Disease Control and Prevention2010 Available from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdfAccessed August 1, 2013
   Google Scholar
• FruehFWAmurSMummaneniPPharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug usePharmacotherapy200828899299818657016
   PubMed Web of Science ®Google Scholar
• GriceGRSeatonTLWoodlandAMMcLeodHLDefining the opportunity for pharmacogenetic intervention in primary carePharmacogenomics200671616516354125
   PubMed Web of Science ®Google Scholar
• CrewsKRHicksJKPuiCHRellingMVEvansWEPharmacogenomics and individualized medicine: translating science into practiceClin Pharmacol Ther201292446747522948889
   PubMed Web of Science ®Google Scholar
• PulleyJMDennyJCPetersonJFOperational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT projectClin Pharmacol Ther2012921879522588608
   PubMed Web of Science ®Google Scholar
• MillsRHagaSBClinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacistsPharmacogenomics201314895796823746189
   PubMed Web of Science ®Google Scholar
• FargherEAEddyCNewmanWPatients’ and healthcare professionals’ views on pharmacogenetic testing and its future delivery in the NHSPharmacogenomics20078111511151918034616
   PubMed Web of Science ®Google Scholar
• PayneKFargherEARobertsSAValuing pharmacogenetic testing services: a comparison of patients’ and health care professionals’ preferencesValue Health201114112113421211494
   PubMed Web of Science ®Google Scholar
• SwenJJGuchelaarHJJust how feasible is pharmacogenetic testing in the primary healthcare setting?Pharmacogenomics201213550750922462740
   PubMed Web of Science ®Google Scholar
• van SchieRMde BoerAMaitland-van der ZeeAHImplementation of pharmacogenetics in clinical practice is challengingPharmacogenomics20111291231123321919599
   PubMed Web of Science ®Google Scholar
• ShieldsAELermanCAnticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?Clin Pharmacol Ther200883463563918323859
   PubMed Web of Science ®Google Scholar
• HagaSBBurkeWGinsburgGSMillsRAgansRPrimary care physicians’ knowledge of and experience with pharmacogenetic testingClin Genet201282438839422698141
   PubMed Web of Science ®Google Scholar
• StanekEJSandersCLTaberKAAdoption of pharmacogenomic testing by US physicians: results of a nationwide surveyClin Pharmacol Ther201291345045822278335
   PubMed Web of Science ®Google Scholar
• BirdJCohen-ColeSAThe three-function model of the medical interview. An educational deviceAdv Psychosom Med19902065882239506
   PubMedGoogle Scholar
• MadadiPJolyYAvardDThe communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot studyJ Popul Ther Clin Pharmacol201118e152e15521467605
   PubMedGoogle Scholar
• RosesADPharmacogenetics and the practice of medicineNature2000405678885786510866212
   PubMed Web of Science ®Google Scholar
• CallardANewmanWPayneKDelivering a pharmacogenetic service: is there a role for genetic counselors?J Genet Couns201221452753522052043
   PubMed Web of Science ®Google Scholar
• RobertsonJAConsent and privacy in pharmacogenetic testingNat Genet200128320720911431685
   PubMed Web of Science ®Google Scholar
• RobertsonJABrodyBBuchananAKahnJMcPhersonEPharmacogenetic challenges for the health care systemHealth Aff (Millwood)200221415516712117126
   PubMed Web of Science ®Google Scholar
• WoelderinkAIbarretaDHopkinsMMRodriguez-CerezoEThe current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studiesPharmacogenomics J2006613716314885
   PubMed Web of Science ®Google Scholar
• HedgecoeA“At the point at which you can do something about it, then it becomes more relevant”: informed consent in the pharmacogenetic clinicSoc Sci Med20056161201121015970231
   PubMed Web of Science ®Google Scholar
• HedgecoeAMContext, ethics and pharmacogeneticsStud Hist Philos Biol Biomed Sci200637356658216980195
   PubMedGoogle Scholar
• CarrollJCRideoutALWilsonBJGenetic education for primary care providers: improving attitudes, knowledge, and confidenceCan Fam Physician20095512e92e9920008584
   PubMed Web of Science ®Google Scholar
• CarrollJCWilsonBJAllansonJGenetiKit: a randomized controlled trial to enhance delivery of genetics services by family physiciansFam Pract201128661562321746696
   PubMed Web of Science ®Google Scholar
• EmeryJWaltonRMurphyMComputer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated casesBMJ20003217252283210875832
   PubMed Web of Science ®Google Scholar
• WatsonEClementsAYudkinPEvaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trialBr J Gen Pract20015147181782111677705
   PubMed Web of Science ®Google Scholar
• HaddyCAWardHMAngleyMTMcKinnonRAConsumers’ views of pharmacogenetics: a qualitative studyRes Social Adm Pharm20106322123120813335
   PubMed Web of Science ®Google Scholar
• LeaDHKaphingstKABowenDLipkusIHadleyDWCommunicating genetic and genomic information: health literacy and numeracy considerationsPublic Health Genomics2011144–527928920407217
   PubMed Web of Science ®Google Scholar
• The Genetic Information Nondiscrimination Act of 2008 [webpage on the Internet]Washington, DCUS Equal Employment Opportunity Commission2008 Available from: http://www.eeoc.gov/laws/statutes/gina.cfmAccessed May 21, 2013
   Google Scholar
• HallMAMcEwenJEBartonJCConcerns in a primary care population about genetic discrimination by insurersGenet Med20057531131615915082
   PubMed Web of Science ®Google Scholar
• KlitzmanRViews of discrimination among individuals confronting genetic diseaseJ Genet Couns2010191688320054623
   PubMed Web of Science ®Google Scholar
• KaphingstKAMcBrideCMWadeCPatients’ understanding of and responses to multiplex genetic susceptibility test resultsGenet Med201214768168722481132
   PubMed Web of Science ®Google Scholar
• KlitzmanRLMisunderstandings concerning genetics among patients confronting genetic diseaseJ Genet Couns201019543044620512408
   PubMed Web of Science ®Google Scholar
• BlossCSWineingerNEDarstBFSchorkNJTopolEJImpact of direct-to-consumer genomic testing at long term follow-upJ Med Genet201350639340023559530
   PubMed Web of Science ®Google Scholar
• 23andme.com [homepage on the Internet]Genetic testing for health, disease, and ancestry2007 [updated August 1, 2013]. Available from: http://23andme.comAccessed July 17, 2013
   Google Scholar
• Zikmund-FisherBJThe right tool is what they need, not what we have: a taxonomy of appropriate levels of precision in patient risk communicationMed Care Res Rev201370Suppl 137S49S22955699
   PubMed Web of Science ®Google Scholar
• MadadiPJolyYAvardDCommunicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefitsClin Pharmacol Ther201088679279520739920
   PubMed Web of Science ®Google Scholar
• HagaSBKawamotoKAgansRGinsburgGSConsideration of patient preferences and challenges in storage and access of pharmacogenetic test resultsGenet Med2011131088789021673581
   PubMed Web of Science ®Google Scholar
• HagaSBBurkeWPharmacogenetic testing: not as simple as it seemsGenet Med200810639139518496219
   PubMed Web of Science ®Google Scholar
• HenriksonNBBurkeWVeenstraDLAncillary risk information and pharmacogenetic tests: social and policy implicationsPharmacogenomics J200882858917486108
   PubMed Web of Science ®Google Scholar
• NetzerCBiller-AndornoNPharmacogenetic testing, informed consent and the problem of secondary informationBioethics200418434436015449406
   PubMed Web of Science ®Google Scholar
• VooraDGinsburgGSClinical application of cardiovascular pharmacogeneticsJ Am Coll Cardiol201260192022742397
   PubMed Web of Science ®Google Scholar
• TanziREThe genetics of Alzheimer diseaseCold Spring Harb Perspect Med2012210pii 006296
   Web of Science ®Google Scholar
• HagaSBO’DanielJMTindallGMLipkusIRAgansRSurvey of US public attitudes toward pharmacogenetic testingPharmacogenomics J201212319720421321582
   PubMed Web of Science ®Google Scholar
• HagaSBO’DanielJMTindallGMLipkusIRAgansRPublic attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditionsGenet Med201113872372821633294
   PubMed Web of Science ®Google Scholar
• CassiniCThauvin-RobinetCVinaultSWritten information to patients in clinical genetics: what’s the impact?Eur J Med Genet201154327728021420514
   PubMed Web of Science ®Google Scholar
• EssexCConsultants could give patients a letter summarising their consultationBMJ199831671327069522815
   PubMed Web of Science ®Google Scholar
• RaoMFogartyPWhat did the doctor say?J Obstet Gynaecol200727547948017701794
   PubMedGoogle Scholar
• HallowellNProviding letters to patients. Patients find summary letters usefulBMJ1998316714718309624093
   PubMed Web of Science ®Google Scholar
• BaumanisLEvansJPCallananNSussweinLRTelephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfactionJ Genet Couns200918544746319462222
   PubMed Web of Science ®Google Scholar
• SanghaKKDircksALangloisSAssessment of the effectiveness of genetic counselling by telephone compared to a clinic visitJ Genet Couns2003122171184
   Google Scholar
• HarrisonHFHarrisonBWWalkerAPScreening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS studyGenet Test200812449150018939938
   PubMedGoogle Scholar
• LinkEParishSArmitageJSEARCH Collaborative GroupSLCO1B1 variants and statin-induced myopathy: a genomewide studyN Engl J Med2008359878979918650507
   PubMed Web of Science ®Google Scholar
• VooraDShahSHSpasojevicIThe SLCO1B1*5 genetic variant is associated with statin-induced side effectsJ Am Coll Cardiol200954171609161619833260
   PubMed Web of Science ®Google Scholar
• PharmGKB: Simvastatin [homepage on the Internet]Stanford, CAThe Pharmacogenomics Knowledgebasec2001–2013 [updated July 1, 2013]. Available from: http://pharmgkb.org/drug/PA451363Accessed July 24, 2013
   Google Scholar